| 000 | 01523 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516180601.0 | ||
| 264 | 0 | _c20140904 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1551-4005 | ||
| 024 | 7 |
_a10.4161/cc.26899 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Luca, Antonella | |
| 245 | 0 | 0 |
_aSrc and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _c2014 |
||
| 300 |
_a148-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLapatinib |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xgenetics |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
| 650 | 0 | 4 |
_aReceptors, CXCR4 _xbiosynthesis |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_asrc-Family Kinases _xbiosynthesis |
| 700 | 1 | _aD'Alessio, Amelia | |
| 700 | 1 | _aGallo, Marianna | |
| 700 | 1 | _aMaiello, Monica R | |
| 700 | 1 | _aBode, Ann M | |
| 700 | 1 | _aNormanno, Nicola | |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 13 _gno. 1 _gp. 148-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cc.26899 _zAvailable from publisher's website |
| 999 |
_c23239968 _d23239968 |
||